跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Primudine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Primudine
Approved
STANDARD
Primudine
Sanjivani Paranteral Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
195eb243c5c7ad4e
Company
Sanjivani Paranteral Limited
Type
Standard
Approval Details
Approval Id
195eb243c5c7ad4e
Drug Approval Philippines Name
Primudine
Product Name
Primudine
Registration Number
DRP-6304-01
Brand Name
Primudine
Generic Name
Ranitidine (as Hydrochloride)
Dosage Form
Solution for Injection (IM/IV)
Dosage Strength
25 mg/mL
Manufacturer
Sanjivani Paranteral Limited
Trader
Apoorv International
Importer
Ambica International Corporation
Distributor
Primus Medicus Distributors Inc.
Issuance Date
26 May 2021
Expiry Date
19 June 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
195eb243c5c7ad4e
Type
Standard
Back to Philippines FDA Approvals